… of pharmacogenomics both in the pharmaceutical industry and in a clinical setting. In drug
discovery, pharmacogenomics … Moreover, pharmacogenomic discoveries show promise as …

… and functional roles, such as GPCR activation and inactivation, their relationships with
diseases, and their potential uses in defining optimized novel drug targets ( see Chapters 7, 8, …

… This chapter focuses on the pharmacogenomic influences on drug … in Chapter 5, although
this chapter will also discuss ADRs related to genetic polymorphisms. Pharmacogenomics is …

… the tools available for pharmacogenomic research and testing… loci, and advances in
pharmacogenomics and toxicogenomic … and more extensively in Chapter 7 and charted in Table …

… All 46 well-crafted chapters, including several consisting of practical clinical examples,
provide an excellent grounding in pharmacogenomics in all its aspects. Clear and well-designed …

… The study of pharmacogenetics and pharmacogenomics … in pharmacogenetics and
pharmacogenomics, including … , and social implications of pharmacogenomics. The second half of …

… ofthe ramifications of pharmacogenomic testing, population … What pharmacogenomics
means — and what it does not — … upon the emerging field of pharmacogenomics. Points of view …

… chapters for this text, I sat for a long while in my office just pondering how I could tell the story
of pharmacogenomics … This is not the case with pharmacogenomics. Although classic drug …

… , pharmacogenomics will in the long run lead to a better understanding of the interaction
between drugs and gene products. The promise of pharmacogenomics … of pharmacogenomics …

… The goal of this chapter is to review the pharmacokinetic and pharmacodynamics basis of
individualized therapy, and briefly discuss the challenges of implementing pharmacogenomics …